-+ 0.00%
-+ 0.00%
-+ 0.00%

PASSAGE BIO INC - PBFT02-TREATED PATIENTS WITH CDR 1 SHOW 54% REDUCTION IN FRONTOTEMPORAL CORTEX ATROPHY AT 12 MONTHS

Reuters·04/20/2026 11:00:01

Please log in to view news